Related Topics News -

     
 Detail   |   Print 
     
來凱醫藥為自研減肥藥LAE102尋求合作夥伴 加快開發及商業化進程
2026-10-13T  
來凱醫藥LAE118治療晚期實體瘤中國臨床研究完成首例入組
2026-09-01T  
《業績》來凱醫藥中期虧損收窄至255萬人民幣
2026-08-26T  
來凱醫藥料中期虧損按年大幅收窄96%
2026-08-17T  
來凱醫藥LAE002新藥上市申請獲內地受理
2026-08-12T  
來凱醫藥主席及高級管理層擬增持 涉資最多5,600萬元
2026-07-02T  
來凱醫藥授予Vasque Bio全球性獨家許可 獲首付款項1,000萬美元
2026-06-10T  
來凱醫藥乳腺癌III期臨床達主要終點 PFS顯著改善
2026-04-15T  
《業績》來凱醫藥全年虧損收窄至2.29億人民幣
2026-03-18T  
來凱醫藥LAE102美國SAD研究成功
2026-03-10T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.